Mitsue Komatsu1, Shuhei Konagaya1, Edgar Y Egawa1, Hiroo Iwata2. 1. Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. 2. Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: iwata@frontier.kuoyo-u.ac.jp.
Abstract
BACKGROUND: Pluripotent stem cells (embryonic stem/induced pluripotent stem cells) have been widely studied as a potential cell source for cell transplantation therapy of Parkinson's disease. However, some difficulties remain to be overcome. These include the need to prepare a large number of dopamine (DA) neurons for clinical use and to culture the cells for a long period to allow their functional maturation and the removal of undifferentiated cells. METHODS: In this study, aggregates of DA neuron precursors were enclosed in alginate-Ca(2+) microbeads, and the encapsulated aggregates were cultured for 25days to induce cell maturation. RESULTS: More than 60% of cells in the aggregates differentiated into tyrosine hydroxylase-positive DA neurons. The aggregates could release DA at the same level as aggregates maintained on culture dishes without encapsulation. In addition, by exposure to a citrate solution, the alginate-Ca(2+) gel layer could be easily removed from aggregates without damaging the DA neurons. When the aggregates were transplanted into rat brain, viable cells were found in the graft at one week post-transplantation, with cells extending neurites into the host tissue. CONCLUSIONS: Cell aggregates encapsulated in alginate-Ca(2+) beads successfully differentiated into mature DA neurons. GENERAL SIGNIFICANCE: The alginate-Ca(2+) microbead is suitable for maintaining DA precursor aggregates for a long period to allow their functional maturation.
BACKGROUND: Pluripotent stem cells (embryonic stem/induced pluripotent stem cells) have been widely studied as a potential cell source for cell transplantation therapy of Parkinson's disease. However, some difficulties remain to be overcome. These include the need to prepare a large number of dopamine (DA) neurons for clinical use and to culture the cells for a long period to allow their functional maturation and the removal of undifferentiated cells. METHODS: In this study, aggregates of DA neuron precursors were enclosed in alginate-Ca(2+) microbeads, and the encapsulated aggregates were cultured for 25days to induce cell maturation. RESULTS: More than 60% of cells in the aggregates differentiated into tyrosine hydroxylase-positive DA neurons. The aggregates could release DA at the same level as aggregates maintained on culture dishes without encapsulation. In addition, by exposure to a citrate solution, the alginate-Ca(2+) gel layer could be easily removed from aggregates without damaging the DA neurons. When the aggregates were transplanted into rat brain, viable cells were found in the graft at one week post-transplantation, with cells extending neurites into the host tissue. CONCLUSIONS: Cell aggregates encapsulated in alginate-Ca(2+) beads successfully differentiated into mature DA neurons. GENERAL SIGNIFICANCE: The alginate-Ca(2+) microbead is suitable for maintaining DA precursor aggregates for a long period to allow their functional maturation.
Authors: Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim Journal: Prog Neurobiol Date: 2018-04-11 Impact factor: 11.685